Nymox Announces US NDA for Fexapotide for BPH

World News: . []

HASBROUCK HEIGHTS NJ Feb 05 2018 GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation NASDAQNYMX announced today that the Company will submit a New Drug Application NDA for Fexapotide Triflutate for the treatment of BPH in the US The C ompany ...

More news and information about Nymox Pharmaceutical Corporation

Published By:

Globe Newswire: 16:15 GMT Monday 5th February 2018

Published: .

Search for other references to "nymox" on SPi News


Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 0751938.
Privacy Policy | Terms and Conditions | Contact Us